USPTO serial 78195944
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Mississauga, Ontario, CA
Mississauga, Ontario, CA
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis | ACTIVE | — |
| 042 | Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 26, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 6, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 6, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 6, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 7, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 7, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 29, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 7, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 15, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| May 5, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2003 | DOCK | ASSIGNED TO EXAMINER | — |